| abstract |
HLIG-1 polypeptides and polynucleotides and methods for producing such polypeptidesnby recombinant techniques are disclosed. Also disclosed are methods for utilizing HLIG-1npolypeptides and polynucleotides in the design of protocols for the treatment of neurologicalndisorders such as Alzheimer's disease, multiple sclerosis and abnormal neural development;nendocrine disorders such as diabetes; and heart disease, among others and diagnostic assays fornsuch conditions. |